{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:19:53Z","timestamp":1773832793266,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.maturitas.2009.12.021","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T06:41:23Z","timestamp":1264142483000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Optimizing bone health in chronic kidney disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Solenne","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.maturitas.2009.12.021_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"6976","key":"10.1016\/j.maturitas.2009.12.021_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.maturitas.2009.12.021_bib3","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib5","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","article-title":"Risk factors for hip fracture among patients with end-stage renal disease","volume":"58","author":"Stehman-Breen","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"Suppl.","key":"10.1016\/j.maturitas.2009.12.021_bib9","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","article-title":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis","volume":"94","year":"1993","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2009.12.021_bib11","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/8756-3282(93)90347-D","article-title":"Interhealth and osteoporosis","volume":"14","author":"Khaltaev","year":"1993","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.maturitas.2009.12.021_bib13","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semnephrol.2009.01.007","article-title":"Diagnosis and treatment of osteoporosis in chronic renal disease","volume":"29","author":"Miller","year":"2009","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.070301","article-title":"Sex differences of human trabecular bone microstructure in aging are site-dependent","volume":"22","author":"Eckstein","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jbiomech.2007.09.003","article-title":"Evaluation of trabecular mechanical and microstructural properties in human calcaneal bone of advanced age using mechanical testing, microCT, and DXA","volume":"41","author":"Mittra","year":"2008","journal-title":"J Biomech"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00774-005-0650-3","article-title":"Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients","volume":"24","author":"Ersoy","year":"2006","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S8756-3282(96)00246-3","article-title":"Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures","volume":"19","author":"Yamaguchi","year":"1996","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.maturitas.2009.12.021_bib23","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Urena","year":"2003","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"10.1016\/j.maturitas.2009.12.021_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","article-title":"A structural approach to renal bone disease","volume":"13","author":"Parfitt","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S8756-3282(98)00159-8","article-title":"Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography","volume":"24","author":"Laib","year":"1999","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.transproceed.2004.12.056","article-title":"Evaluation of cortical bone by peripheral quantitative computed tomography in renal transplant recipients","volume":"37","author":"Negri","year":"2005","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s001980050089","article-title":"Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis","volume":"8","author":"Russo","year":"1998","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9290(03)00174-X","article-title":"Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography","volume":"37","author":"Hasegawa","year":"2004","journal-title":"J Biomech"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00774-006-0730-z","article-title":"Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D","volume":"25","author":"Obatake","year":"2007","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00198-004-1655-9","article-title":"The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure","volume":"16","author":"Tsuchida","year":"2005","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.jrn.2008.10.023","article-title":"Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management?","volume":"19","author":"Bacchetta","year":"2009","journal-title":"J Ren Nutr"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1542-4758.2006.00128.x","article-title":"Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients","volume":"10","author":"Negri","year":"2006","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmri.20085","article-title":"Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone","volume":"20","author":"Wehrli","year":"2004","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.maturitas.2009.12.021_bib35","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejrad.2008.04.064","article-title":"Advances in osteoporosis imaging","volume":"71","author":"Bauer","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.maturitas.2009.12.021_bib37","article-title":"Bone microarchitecture: comparison hemodialysis vs stage II\u2013IV chronic kidney disease","author":"Pelletier","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.maturitas.2009.12.021_bib39","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib40","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5414\/CNP70296","article-title":"Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3\u20135","volume":"70","author":"Lehmann","year":"2008","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.mnh.0000172718.49476.64","article-title":"Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology","volume":"14","author":"D\u2019Amour","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1373\/clinchem.2004.040485","article-title":"Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19","volume":"51","author":"D\u2019Amour","year":"2005","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2009.12.021_bib47","article-title":"Parathyroid hormone measurement in CKD","author":"Souberbielle","year":"2009","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.maturitas.2009.12.021_bib48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","article-title":"Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH (1\u201384) is overproduced in primary and secondary hyperparathyroidism","volume":"49","author":"D\u2019Amour","year":"2003","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1\u201384 and PTH \u201c7-84\u201d in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfg144","article-title":"Influence of PTH assay methodology on differential diagnosis of renal bone disease","volume":"18","author":"Reichel","year":"2003","journal-title":"Nephrol Dial Transpl"},{"issue":"4 Suppl. 3","key":"10.1016\/j.maturitas.2009.12.021_bib51","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/17453677408989691","article-title":"Long-term effects of high phosphate intake on parathyroid hormone levels and bone metabolism","volume":"45","author":"Jowsey","year":"1974","journal-title":"Acta Orthop Scand"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1172\/JCI108781","article-title":"Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog","volume":"60","author":"Rutherford","year":"1977","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib54","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic bone disease in chronic kidney disease","volume":"18","author":"Martin","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.maturitas.2009.12.021_bib56","first-page":"pii45","article-title":"EBPG guideline on nutrition","volume":"22","author":"Fouque","year":"2007","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N Engl J Med"},{"issue":"4 Suppl. 1","key":"10.1016\/j.maturitas.2009.12.021_bib58","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1053\/ajkd.2001.27394","article-title":"Vascular calcification and inorganic phosphate","volume":"38","author":"Giachelli","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.semnephrol.2004.06.005","article-title":"Mechanisms of vascular calcification in uremia","volume":"24","author":"Giachelli","year":"2004","journal-title":"Semin Nephrol"},{"issue":"9","key":"10.1016\/j.maturitas.2009.12.021_bib60","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2009.12.021_bib61","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. a single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.maturitas.2009.12.021_bib63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-139X.2005.18408.x","article-title":"Vitamin D treatment in chronic kidney disease","volume":"18","author":"Andress","year":"2005","journal-title":"Semin Dial"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfg595","article-title":"Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure","volume":"19","author":"Rix","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"10.1016\/j.maturitas.2009.12.021_bib66","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.maturitas.2009.12.021_bib67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypovitaminosis D, and mortality in the United States","volume":"76","author":"Mehrotra","year":"2009","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.maturitas.2009.12.021_bib69","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.maturitas.2009.12.021_bib70","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","article-title":"Cinacalcet and achievement of the NKF\/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice\u2014the ECHO observational study","volume":"24","author":"Urena","year":"2009","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib71","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib72","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib73","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.maturitas.2009.12.021_bib74","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ki.2008.407","article-title":"Cinacalcet suppresses calcification of the aorta and heart in uremic rats","volume":"74","author":"Kawata","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.maturitas.2009.12.021_bib76","article-title":"Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008","author":"Pelletier","year":"2009","journal-title":"Nephrol Ther"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1542-4758.2007.00155.x","article-title":"Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study","volume":"11","author":"Slinin","year":"2007","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1016\/j.maturitas.2009.12.021_bib78","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/ajcn\/82.5.921","article-title":"Dietary protein content and the diet's net acid load: opposing effects on bone health","volume":"82","author":"Sebastian","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1359\/JBMR.040204","article-title":"Dietary protein and bone health","volume":"19","author":"Rizzoli","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib80","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3945\/ajcn.2009.28285","article-title":"Effect of high-normal compared with low-normal arterial pH on protein balances in automated peritoneal dialysis patients","volume":"90","author":"Mehrotra","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.ackd.2009.07.007","article-title":"Anabolic and catabolic mechanisms in end-stage renal disease","volume":"16","author":"Johansen","year":"2009","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib82","article-title":"Correction of chronic metabolic acidosis for chronic kidney disease patients","author":"Roderick","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib83","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"73","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.maturitas.2009.12.021_bib85","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1797.2005.00436.x","article-title":"Effects of short-term alendronate on bone mineral density in haemodialysis patients","volume":"10","author":"Wetmore","year":"2005","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib87","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.ajkd.2003.08.023","article-title":"Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism","volume":"42","author":"Lu","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.maturitas.2009.12.021_bib88","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.12.021_bib89","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.01970309","article-title":"Physical activity and mortality in chronic kidney disease (NHANES III)","author":"Beddhu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.jrn.2008.10.012","article-title":"New measurements of energy expenditure and physical activity in chronic kidney disease","volume":"19","author":"Mafra","year":"2009","journal-title":"J Ren Nutr"},{"issue":"6 Suppl.","key":"10.1016\/j.maturitas.2009.12.021_bib91","doi-asserted-by":"crossref","first-page":"526S","DOI":"10.1080\/07315724.2005.10719501","article-title":"Dietary protein: an essential nutrient for bone health","volume":"24","author":"Bonjour","year":"2005","journal-title":"J Am Coll Nutr"},{"issue":"7120","key":"10.1016\/j.maturitas.2009.12.021_bib92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.maturitas.2009.12.021_bib93","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/ndt\/gfn260","article-title":"The bone-renal axis in early chronic kidney disease: an emerging paradigm","volume":"23","author":"Danziger","year":"2008","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib94","doi-asserted-by":"crossref","first-page":"F470","DOI":"10.1152\/ajprenal.90538.2008","article-title":"FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?","volume":"296","author":"Razzaque","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib95","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.maturitas.2009.12.021_bib96","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1525-139X.2007.00308.x","article-title":"Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease","volume":"20","author":"Stubbs","year":"2007","journal-title":"Semin Dial"},{"issue":"7","key":"10.1016\/j.maturitas.2009.12.021_bib97","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.maturitas.2009.12.021_bib98","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.maturitas.2009.12.021_bib99","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.maturitas.2009.12.021_bib100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","article-title":"Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients","volume":"73","author":"Urena Torres","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.maturitas.2009.12.021_bib101","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factors (FGF)-23 are associated with increased mortality in long haemodialysis patients","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1016\/j.maturitas.2009.12.021_bib102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib103","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.maturitas.2009.12.021_bib104","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.maturitas.2009.12.021_bib105","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ncpendmet0667","article-title":"Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism?","volume":"3","author":"Razzaque","year":"2007","journal-title":"Natl Clin Pract Endocrinol Metab"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209004915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209004915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:49:21Z","timestamp":1759913361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512209004915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0378512209004915"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.12.021","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing bone health in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}